InterventionsHuman trial
Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia
Leukemia
The paper
Guru Murthy GS, Shah B, Badar T et al.
Leukemia · 14 Sep 2026
